(Q35353614)

7 August 2017

1 reference

title

New carriers and adjuvants in the development of vaccines (English)

1 reference

7 August 2017

G. Del Giudice

1

1 reference

PubMed ID

1388847

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1388847

21 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

1388847

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1388847

21 September 2022

publication date

1 August 1992

1 reference

Current Opinion in Immunology

7 August 2017

1 reference

7 August 2017

4

1 reference

7 August 2017

4

1 reference

7 August 2017

454-459

1 reference

Targeting and controlled release of antigens for the effective induction of secretory antibody responses

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Synthetic T and B cell recognition sites: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Polysaccharide-protein conjugates: a new generation of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Prevention of invasive Haemophilus influenzae type b disease: lessons from vaccine efficacy trials

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Use of Prior Vaccinations for the Development of New Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Model using a peptide with carrier function for vaccination against different pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Exact prediction of a natural T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Identification of two promiscuous T cell epitopes from tetanus toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Mycobacterial heat-shock proteins as carrier molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Predicting the adsorption of proteins by aluminium-containing adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Improvement of hepatitis B vaccine by the use of a new adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Syphilis vaccine: up-regulation of immunogenicity by cyclophosphamide, Ribi adjuvant, and indomethacin confers significant protection against challenge infection in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Enhancement of in vivo and in vitro T cell response against measles virus haemagglutinin after its incorporation into liposomes: effect of the phospholipid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Enhanced antibody response to liposome-associated protein antigens: preferential stimulation of IgG2a/b production

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

The iscom: an immunostimulating system

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Non-inflammatory peptide fragments of IL1 as safe new-generation adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Adjuvant effect of human growth hormone with an inactivated flavivirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Serological responses of rams to a Brucella ovis-vitamin E adjuvant vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Vitamin E adjuvant formulations in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Induction of immune response to protein antigens by subcutaneous co-injection with water-miscible vitamin A derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980038-5

7 January 2021

10.1016/S0952-7915(06)80038-5

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

1388847